Almirall and the Centre for Genomic Regulation (CRG) Advance Research on Atopic Dermatitis 02/07/2024 Healthcare Access to innovation Rare diseases The research objectives of this collaboration include the characterization of experimental models of AD to identity... Partners - Almirall
Augustine Therapeutics raises EUR 17 million in a series a first closing to advance lead c... 01/07/2024 Healthcare Access to innovation Financing Proceeds will advance lead candidate AGT100216, a peripherally restricted and selective HDAC6 inhibitor, into a first-in... Partners - Asabys Partners
The European authority HERA visits HIPRA for its productive capacity in the face of future... 27/06/2024 Healthcare Access to innovation Drug discovery Industrial biotechnology The top leadership team from HERA (Health Emergency Preparedness and Response), the European Commission's authority for... Partners - HIPRA HUMAN HEALTH S.L.U.
Oryzon announces presentation of final data from PORTICO, vafidemstat’s global Phase IIb ... 26/06/2024 Healthcare Access to innovation Rare diseases Advanced therapies Seleccionada para presentación oral. La conferencia se celebrará en Milán del 21-23 de septiembre. Partners - Oryzon Genomics
AseBio and the Ministry of Health analyze the challenges and opportunities of Artificial I... 25/06/2024 Healthcare Access to innovation The event "Challenges and Opportunities for Spain in the Application of AI in Health Data Spaces," organized by AseBio... AseBio
AseBio and the Ministry of Health analyze the challenges and opportunities of Artificial I... 25/06/2024 The event "Challenges and Opportunities for Spain in the Application of AI in Health Data Spaces," organized by AseBio... AseBio
Alira Health Publishes a White Paper on the Impact of New European Union Regulations on Ad... 21/06/2024 Healthcare Access to innovation Drug discovery It provides an overview of the key changes that will impact access to innovative medicines and advanced therapies in the... Partners
ORYZON presents preliminary data from ongoing Phase Ib FRIDA trial with iadademstat plus ... 14/06/2024 Healthcare Access to innovation Drug discovery Rare diseases Data from the first two cohorts demonstrated that combination of iadademstat plus gilteritinib was safe and showed... Partners - Oryzon Genomics
La biotecnología revoluciona la detección temprana del cáncer de próstata, cuya incidencia... 11/06/2024 Salud Acceso a la innovación Digitalización La biotecnología es fundamental en el diagnóstico, tratamiento y seguimiento del cáncer de próstata y desempeña un... AseBio
Biotechnology revolutionizes early detection of prostate cancer, the incidence of which co... 11/06/2024 Biotechnology is central to the diagnosis, treatment and follow-up of prostate cancer and plays a broad role across the... AseBio
